Jacob M. Chacko
2019
In 2019, Jacob M. Chacko earned a total compensation of $672.1K as President and Chief Executive Officer at Oric Pharmaceuticals, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $194,900 |
|---|---|
| Salary | $455,833 |
| Other | $21,396 |
| Total | $672,129 |
Chacko received $455.8K in salary, accounting for 68% of the total pay in 2019.
Chacko also received $194.9K in non-equity incentive plan and $21.4K in other compensation.
Rankings
In 2019, Jacob M. Chacko's compensation ranked 10,843rd out of 13,971 executives tracked by ExecPay. In other words, Chacko earned more than 22.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,843 out of 13,971 | 22nd |
Division Manufacturing | 4,389 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,713 out of 2,200 | 22nd |
Industry group Drugs | 1,468 out of 1,886 | 22nd |
Industry Pharmaceutical Preparations | 1,084 out of 1,398 | 23rd |
Source: SEC filing on April 26, 2021.
Chacko's colleagues
We found two more compensation records of executives who worked with Jacob M. Chacko at Oric Pharmaceuticals in 2019.
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021